Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PPARgamma signaling: one size fits all?

Anjali Jain1, David B Agus

  • 1Louis Warschaw Prostate Cancer Center, Cedars-Sinai Prostate Cancer Center, Los Angeles, California 90048, USA.

Cell Cycle (Georgetown, Tex.)
|October 7, 2004
PubMed
Summary

Peroxisome proliferator-activated receptor gamma (PPARgamma) activation in cancer cells yields complex outcomes. Its effects depend on ligand affinity, cell type, and interconnected signaling pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Curious "Mickey Mouse" Sign: Physiological FAPI Uptake in Uterus Didelphys on 68Ga-FAPI PET/CT.

Clinical nuclear medicine·2026
Same author

Nonuniformity in a Certified <sup>68</sup>Ge PET Cylinder Phantom: Implications for Normalization Quality Assurance.

Journal of nuclear medicine technology·2026
Same author

Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure.

Frontiers in artificial intelligence·2026
Same author

⁶⁸Ga-FAPI PET/CT Unmasks Extensive Metastatic Invasive Lobular Breast Cancer when Conventional Imaging Falls Short.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Impact of Point-Spread Function Modeling on Image Quality in <sup>68</sup>Ga-PSMA PET/CT.

Journal of nuclear medicine technology·2026
Same author

Integration of ⁶⁸Ga-DOTA-TOC PET/CT into radiotherapy planning for intracranial meningiomas: A precision-imaging approach to tumor delineation.

Annals of nuclear medicine·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Peroxisome proliferator-activated receptor gamma (PPARgamma) is a nuclear receptor involved in various cellular processes.
  • PPARgamma activation has been investigated for its role in cancer, with diverse reported effects.

Purpose of the Study:

  • To elucidate the multifaceted outcomes of PPARgamma activation in cancer cells.
  • To understand the regulatory factors influencing PPARgamma signaling in oncology.

Main Methods:

  • Analysis of PPARgamma signaling pathways.
  • Investigation of ligand-dependent effects.
  • Evaluation of cellular context and network interactions.

Main Results:

  • PPARgamma activation does not produce a uniform effect in cancer cells.
  • Outcomes are contingent upon specific PPARgamma ligand characteristics.
  • Target cell context and associated signaling networks significantly modulate PPARgamma activity.

Conclusions:

  • The impact of PPARgamma activation in cancer is highly context-dependent.
  • Understanding ligand affinity, cell type, and signaling networks is crucial for predicting PPARgamma's role in cancer.

Related Experiment Videos